Most Recent
AstraZeneca has brought court proceedings to block Australian drug maker Pharmacor from making a generic version of its heart attack drug Brilinta.
The scope of protection for geographical indications will be at issue in India's appeal of a decision that barred it from registering a trade mark for basmati rice.
INPEX has won a bid to cross-examine AkzoNobel's solicitors about discovery at the end of an 11-week trial over allegedly defective paint used on the $45 billion Ichthys natural gas project.
Novartis unit Sandoz is appealing a tribunal decision in favour of pharmaceutical company Lundbeck over a licence to sell a generic version of leading antidepressant Lexapro.
A Victorian barrister found guilty of contempt for representing her sons despite an order barring her from practicing can't re-open reviews of two decisions denying her a certificate.
If it takes up the Federal Court's ruling in favour of solicitors seeking to earn a cut from a class action, the High Court will be asked to overrule its 2019 decision against common fund orders.
Human rights group Save the Children has lost its fight to release Australians held in a Syrian refugee camp after the High Court refused its special leave bid.
Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.
A court has refused leave to appeal a permanent stay of a class action run, funded and led by lawyer Andrew Hamilton against Google and Meta that challenged their crypto ad bans.